AMAzadeh Motavallian

Azadeh Motavallian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Azadeh Motavallian has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Sasan Andalib

    Research Unit of Neurology, Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, 5230 Odense, Denmark

    4 shared publications
  • Forough Aghajani Torshkooh

    Department of Pharmacology and Toxicology, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran

    3 shared publications
  • Paridokht Karimian

    Department of Pathology and Histology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

    3 shared publications
  • Mohsen Minaiyan

    Department of Pharmacology and Toxicology, Faculty of Pharmacy and Pharmaceutical Sciences Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

    2 shared publications
  • Saba Bouzari

    Student Research Committee, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran

    2 shared publications
  • Alireza Abed

    Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 8146-73461, Iran

    1 shared publication

Latest Publications

  • Open Access

    Pramipexole Exerts Beneficial Effects in a Rat Model of Acetic Acid-Induced Colitis via Modulating Inflammation

    by Azadeh Motavallian, Foad Ghazizadeh, Sareh Pastaki Khoshbin, Paridokht Karimian, Forough Aghajani Torshkooh

    Background: Inflammatory bowel disease (IBD) is a serious public health problem worldwide. The existing therapy options for IBD are limited and can cause severe difficulties, and thus require more research on alternative therapeutic techniques. Pramipexole is a dopamine receptor agonist with anti-inflammatory effects that was recently discovered. Given the importance of dopaminergic pathways in ulcerative colitis inflammation, we tested pramipexole’s efficacy in a rat colitis model in this study. Materials and Methods: Colitis was induced by administering 3% acetic acid intrarectally. Rats were randomly assigned to one of six groups: normal, colitis control, dexamethasone (1 mg/kg; i.p.), and pramipexole (0.25, 0.5, and 1 mg/kg; i.p.). In intestinal samples, macroscopic and microscopic lesion ratings, pro-inflammatory cytokine levels (tumor necrosis factor alpha, interleukin-6, and interleukin-1 beta), and myeloperoxidase (MPO) activity were evaluated. Results: Compared to the colitis control group, pramipexole (0.5 and 1 mg/kg) substantially reduced macroscopic and microscopic intestinal damage, pro-inflammatory cytokine levels, and MPO activity. Furthermore, the indices mentioned above were considerably lower in the dexamethasone treatment group compared to the colitis control group. Conclusions: Our findings indicate that pramipexole has favorable benefits in treating experimental colitis; however, further research is required to determine its clinical value as an IBD therapeutic agent.


  • Open Access

    Effects of Methanol Extract from the Peel of Red Onion (Allium cepa L.) on Ulcerative Colitis Induced by Acetic Acid in Wistar Rats

    by Azadeh Motavallian, Fatemeh Yousefbeyk, Foad Ghazizadeh, Paridokht Karimian, Chakavak Roohibakhsh Dehbaneh, Saba Bouzari, Forough Aghajani Torshkooh

    Background: Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). The urgent need to discover new medicines for the treatment of UC has led to a substantial amount of research annually. Objectives: This study aimed to explore the potential beneficial effects of Allium cepa L. peel methanolic extract (ACPME) on experimental ulcerative colitis in rats. Methods: The extraction of red onion peel (Allium cepa) was performed using the percolation method. Total flavonoid and phenolic contents were determined using aluminum chloride and Folin-Ciocalteu techniques, respectively. Ulcerative colitis was induced by intrarectal administration of 2 mL of 3% acetic acid. The animals were divided into six groups: The normal group, the colitis control group, groups treated with ACPME (50, 100, and 150 mg/kg body weight; 4 days of treatment), and the group treated with dexamethasone (1 mg/kg). Macroscopic, histological, and biochemical evaluations (MPO, IL-6, IL-1 beta, and TNF-alpha) were conducted on distal colon samples to assess the extract's efficacy. Results: The total phenolic content of the extract was 223.38 ± 0.002 mg of gallic acid equivalent per gram of dry extract, while the total flavonoid content was 49.42 ± 0.008 mg of quercetin equivalent per gram of extract. Compared to the colitis control group, ACPME administration (50 and 100 mg/kg) significantly reduced macroscopic and microscopic colon damage, pro-inflammatory cytokine levels, and MPO activity in colon samples. Conclusions: The present study demonstrated that ACPME could have a beneficial impact on experimental colitis. This effect may be partly due to modulating neutrophil infiltration and pro-inflammatory cytokines such as IL-6, IL-1 beta, and TNF-alpha. However, further research is required to substantiate these effects.


  • Open Access

    Assessment of Protective Effects of Carvacrol on Haloperidol-Induced Oxidative Stress and Genotoxicity in Human Peripheral Blood Lymphocytes

    by Ehsan Zamani, Alireza Ahmadi Shad, Hediye Fatemi, Saba Mahboubi, Azadeh Motavallian, Mehdi Evazalipour

    Haloperidol is a first-generation antipsychotic drug that has several indications in a wide range of mental conditions. The extensive prescription of haloperidol is correlated with some less-known adverse effects such as genotoxicity. Carvacrol is a monoterpenoid mainly found in oregano and thyme. It has the potential to scavenge free radicals in addition to increasing antioxidant defense enzyme activities and glutathione levels. In this study, we attempted to explore the possible potential of haloperidol in inducing genotoxicity in human peripheral lymphocytes as well as the protective role of carvacrol against this effect. The lymphocytes were divided into separate groups as follows: control group (cosolvent and NS); carvacrol group (5μM); haloperidol group (25, 50, and 100ng/ml); haloperidol (25, 50, and 100ng/ml)+carvacrol (5μM); positive control (0.8μg/ml Cisplatin). After 24 hours of treatment, we conducted a cytokinesis-Block micronucleus test and an alkaline comet assay in order to determine genetic damage. Additionally, we measured glutathione and MDA levels as the biomarkers associated with oxidative stress. Significant increases in the levels of genotoxicity biomarkers (micronucleus frequency, DNA percentage in tail and tail moment) were observed in haloperidol-treated cells. The result of our oxidative stress tests also demonstrated that haloperidol had the potential to induce oxidative stress via reducing the levels of glutathione and increasing lipid peroxidation. Treatment with carvacrol significantly decreased the genotoxic events. It can be presumed that the induction of oxidative stress by haloperidol is the critical event associated with haloperidol-mediated genotoxicity. Therefore, using carvacrol as a natural antioxidant protected human lymphocytes against haloperidol genetic damage.


  • An investigation of the anti-inflammatory effects of gabapentin on acetic acid-induced colitis in rats

    by Azadeh Motavallian, Saba Bouzari, Ehsan Zamani, Paridokht Karimian, Sara Dabirian, Mehdi Molavi, Forough Aghajani Torshkooh

    Inflammatory bowel disease (IBD) is considered a chronic inflammatory gastrointestinal disease with treatment options which exhibit low efficacies and lead to considerable side effects. Hence, the challenge to alleviate IBD complications is remained to be resolved. The purpose of this study is evaluating anti-inflammatory impacts of gabapentin on acetic acid-induced colitis in rats. Colitis was induced by the instillation of 2 mL of 3% acetic acid solution into rat’s colons. Rats were randomly allocated into six groups including normal group, colitis control group, gabapentin-treated groups (25, 50, and 100 mg/kg; i.p.), and dexamethasone-treated group (1 mg/kg; i.p.). Based on the macroscopic assessment besides histological and biochemical findings [myeloperoxidase (MPO), pro-inflammatory cytokines], the efficacy of gabapentin was investigated. Gabapentin (50 and 100 mg/kg), and dexamethasone considerably reduced macroscopic and microscopic colonic lesions induced by acetic acid in rats in comparison with colitis control group. These results were confirmed by reduced levels of MPO activity and colonic concentrations of interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha, in inflamed colon tissue. Our data demonstrated that gabapentin exerts profitable impacts in experimental colitis that might be ascribed to its anti-inflammatory features and thus can be a potential therapeutic agent for IBD treatment.


  • Multiple sclerosis and mitochondrial gene variations: A review

    by Sasan Andalib, Mahnaz Talebi, Ebrahim Sakhinia, Mehdi Farhoudi, Homayoun Sadeghi-Bazargani, Azadeh Motavallian, Yones Pilehvar-Soltanahmadi


  • Open Access

    Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat

    by Azadeh Motavallian, Mohsen Minaiyan, Mohammad Rabbani, Sasan Andalib, Parvin Mahzouni

    Introduction: There is a pressing need for research leading to the development of new effective drugs with lower side effects and more efficacy for treating inflammatory bowel disease (IBD). The analgesic and anti-inflammatory properties of 5-Hydroxytryptamine (5-HT)-3 receptor antagonists have been shown in in vivo and in vitro studies. The present study was designed to investigate the effects of tropisetron, a 5-HT3 receptor antagonist, on an immune-based animal model of IBD. Methods: In the present study, the trinitrobenzenesulfonic acid (TNBS) model of colitis in the rat was used. Two hours after induction of colitis in rats, tropisetron (2 mg/kg), dexamethasone (1 mg/kg), meta-chlorophenylbiguanide (mCPBG, 5 mg/kg), a 5-HT3 receptor agonist, or tropisetron + mCPBG were intraperitoneally (i.p.) administrated for 6 days. Animals were then sacrificed; macroscopic, histological, biochemical (myeloperoxidase [MPO]) assessments and ELISA test (tumor necrosis factor-alpha, interleukin-6 and interleukin-1 beta) were performed on distal colon samples. Results: Tropisetron or dexamethasone treatment significantly reduced macroscopic and microscopic colonic damages. In addition, a significant reduction in MPO activity and colonic levels of inflammatory cytokines was seen. The beneficial effects of tropisetron were antagonized by concurrent administration of mCPBG. Conclusion: The present study indicates that the protective effects of tropisetron on TNBS-induced colitis can be mediated by 5-HT3 receptors.


    • 1 May 2013
      • Vol. 4  (5) , 517-522
    Open Access

    Association of Polymorphism of Ser311cys Paraoxonase-2 Gene with Type 2 Diabetes Mellitus in Iran

    by Sasan Andalib, Golnaz Vaseghi, Azadeh Motavallian, Hamid Mirmohamad Sadeghi, Azadeh Eshraghi, Masoud Amini, Amir-Reza Majlesi

    Background: It is believed that paraoxonase-2 gene polymorphism is associated with type 2 diabetes. This study is aimed to investigate the association between paraoxonase-2 gene polymorphism and type 2 diabetes in an Iranian population. Methods: This study was performed on 200 individuals including 100 diabetics and 100 healthy subjects. Genomic DNA was extracted from peripheral blood leukocytes, and PCR-RFLP was carried out. Palindromic sequence in PON2 gene was recognized by Dde1 restriction endonuclease. In order to visualize restriction products, electrophoresis was carried out using polyacrylamide gel (8%) and ethidium bromide staining. Results: The expected PCR product of 331 bp was obtained. Digestion of this product with DdeI showed four Ser homozygotes, three Cys homozygotes, and five Ser311 Cys heterozygotes. The gene frequency of Cys (C) in diabetic subjects was significantly higher than in healthy subjects. Conclusions: This study suggests that an association exists between Ser311 Cys polymorphism and type-2 diabetes mellitus.


  • Open Access

    Does Cisapride, as a 5HT4Receptor Agonist, Aggravate the Severity of TNBS-Induced Colitis in Rat?

    by Azadeh Motavallian, Mohsen Minaiyan, Mohammad Rabbani, Parvin Mahzouni, Sasan Andalib, Alireza Abed, Mohammad Reza Babavalian

    There is a pressing need for research that will lead to the reveal of targets designed to analyse the possible pathways for the treatment of IBD. Because of the probable involvement of serotonin in inflammatory conditions of intestine and the important role of 5HT4receptors in GI function, the investigation of the role of 5HT4receptors in the pathogenesis of IBD will be interesting. The aim of this study was to investigate the effects of cisapride, a 5HT4receptor agonist, in trinitrobenzenesulfonic-acid-(TNBS) induced rat colitis. Two hours subsequent to induction of colitis using TNBS in rats, cisapride (2 mg/kg, intraperitoneally (i.p); 4 mg/kg, orally (p.o)) and dexamethasone (1 mg/kg, i.p; 2 mg/kg, p.o) were administrated for 6 days. Animals were thereafter euthanized; macroscopic, histological, and biochemical assessments and ELISA test were carried out on distal colon samples. Our data showed that dexamethasone treatment (i.p, p.o) significantly decreased macroscopic and microscopic damage and also biochemical markers, but there were no significant differences in aforementioned parameters between cisapride (i.p or p.o) and TNBS-treated rats. It can be deduced that because the severity of colitis produced by TNBS is massive (through various pathways), cisapride could not bring about more colitis damages through 5HT4receptors. Based on the present study further researches are required for investigating the exact roles of 5HT4receptors in the pathogenesis of ulcerative colitis.